About this trial
In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Those over 18 years of age,
Those in ASA I-III class,
Those who have undergone planned elective surgery under general anesthesia,
Those who have been informed about the study in advance and given their consent.
Disqualifiers
Those under 18 years of age,
Those who underwent emergency intervention,
Those in the ASA-Ⅳ class,
Those who underwent regional anesthesia,
Trial population
Patients over 18 years of age, in ASA class I-III, who have undergone planned elective surgery under general anesthesia, and who have been informed and given informed consent in advance of the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
EARLY WARNING SCORE
Procedure/SurgeryIn the RECO-EWS scoring system we designed; 0-7 low risk, 7-10 medium risk, ≥10 high risk, postoperative stay findings of high-risk patients and, if necessary, new cut-off values are determined for each parameter in the scoring system according to the analysis results.
Treatment groups
Trial outcomes
Primary outcomes
RECO-EWS
0-7 low risk, 7-10 medium risk, ≥10 high risk
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Istinye University
Lead sponsor
Haseki Training and Research Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: